Lucid Scientific is Supporting Targeting Mitochondria 2024

Lucid Logo

Lucid Scientific is a sponsor at the 15th WMS Annual Meeting, Targeting Mitochondria 2024, on October 29-31 at DoubleTree by Hilton Berlin Ku'damm, Berlin, Germany.

Lucid Scientific: Unlocking Cellular Insights in Real-Time

Lucid Scientific is a pioneering biotechnology company dedicated to transforming cell culture research. Our flagship product, the Resipher, is the world's first real-time cell culture monitor for measuring oxygen consumption rate (OCR) directly within standard incubator environments.

Revolutionizing Cell Respiration Analysis:

Traditional methods for measuring OCR require removing cells from the incubator, disrupting their growth and introducing measurement errors. Resipher eliminates this disruption with its innovative non-invasive approach.

Empowering Researchers with Unparalleled Benefits:

  • Continuous, Real-Time Monitoring: Gain uninterrupted insights into cellular respiration throughout your experiment.
  • Non-invasive Measurement: Our high-resolution optical sensors monitor oxygen levels without disturbing your cells.
  • Detailed Data Acquisition: Resipher provides not only the overall OCR but also high-resolution oxygen gradient data within each well.
  • Remote Accessibility: Securely stream data to the cloud and access it from any device for enhanced collaboration and efficiency.
  • Simplified Workflow: Resipher integrates seamlessly into existing workflows, utilizing standard microplates and disposable lids that fit directly within your incubator.

Lucid Scientific is committed to providing researchers with the tools they need to unlock deeper cellular insights, leading to advancements in various fields such as:

  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Metabolic Disease Research

Lucid Scientific Website:

Join us in revolutionizing cell culture research. Visit our website https://lucidsci.com/ to learn more about Resipher and how it can empower your research.

Mitochondria in the Press & Media

  • 1
  • 2
Prev Next

 

News archive